1 study found for:    22449293 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study
Condition: Pulmonary Embolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Enoxaparin overlapping with and followed by VKA

Indicates status has not been verified in more than two years